Articles | EuroIntervention

10.4244/EIJV15I16A251 • Mar 20, 2020

Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out

Giacoppo D, Tarantini G

free

10.4244/EIJV15I16A252 • Mar 20, 2020

Myocardial fibrosis in severe aortic stenosis: how and when should we measure it?

Delgado V, Kong W, Bax J

free

10.4244/EIJV15I16A253 • Mar 20, 2020

How should procedure-related myocardial infarction be defined, and does it matter? (Spoiler alert – it does!)

Stone GW

free

10.4244/EIJV15I16A254 • Mar 20, 2020

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Spaulding C

free

Clinical research

10.4244/EIJ-D-19-00602 • Mar 20, 2020

Stroke after transcatheter edge-to-edge mitral valve repair: a systematic review and meta-analysis

Barros da Silva P, Sousa J, Oliveiros B, Donato H, Costa M, Gonçalves L, Teixeira R

free

Preclinical research

10.4244/EIJ-D-19-00939 • Mar 20, 2020

A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention

Sathananthan J, Fraser R, Hatoum H, Barlow A, Stanová V, Allen K, Chhatriwalla A, Rieu R, Pibarot P, Dasi L, Søndergaard L, Wood DA, Webb JG

free

Clinical research

10.4244/EIJ-D-19-00641 • Mar 20, 2020

Outcomes of myocardial fibrosis in patients undergoing transcatheter aortic valve replacement

Sugiura A, Weber M, von Depka A, Tabata N, Shamekhi J, Al-Kassou B, Nickenig G, Werner N, Sinning J, Sedaghat A

free

Image – Interventional flashlight

10.4244/EIJ-D-19-00609 • Mar 20, 2020

Anticipating coronary obstruction with three-dimensional printing in transcatheter aortic valve implantation

So C, Fan Y, Wu E, Lee A

free

Short report

10.4244/EIJ-D-19-00291 • Mar 20, 2020

Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure

Guimarães L, Bergeron S, Bernier M, Rodriguez-Gabella T, del Val D, Pibarot P, Eigler N, Abraham W, Rodés-Cabau J

free

Clinical research

10.4244/EIJ-D-19-00484 • Mar 20, 2020

Incidence of “Shocktopics” and asynchronous cardiac pacing in patients undergoing coronary intravascular lithotripsy

Wilson S, Spratt J, Hill J, Spence M, Cosgrove C, Jones J, Strange J, Halperin H, Walsh S, Hanratty C

free

Clinical research

10.4244/EIJ-D-19-00773 • Mar 20, 2020

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Munzel T, Cequier A, Buono A, Serruys PW, Sabaté M

free

Clinical research

10.4244/EIJ-D-19-00737 • Mar 20, 2020

Periprocedural elevated myocardial biomarkers and clinical outcomes following elective percutaneous coronary intervention: a comprehensive dose-response meta-analysis of 44,972 patients from 24 prospective studies

Li Y, Pei H, Bulluck H, Zhou C, Hausenloy D

free

Clinical research

10.4244/EIJ-D-18-01080 • Mar 20, 2020

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne RA, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys PW

free

Image – Interventional flashlight

10.4244/EIJ-D-19-00214 • Mar 20, 2020

Left main bifurcation PCI with the culotte technique using two self-apposing stents

Scotti A, Nai Fovino L, Pavei A, Tarantini G

free

Short report

10.4244/EIJ-D-18-00172 • Mar 20, 2020

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials

Gil R, Bil J, Kern A, Ingio Garcia L, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A

free